Korsana Biosciences

Korsana Biosciences is a biotechnology company operator dedicated to alleviating the burden of neurodegenerative diseases by discovering and developing entirely new, industry-leading therapies. The company's proprietary platform is a shuttle technology capable of penetrating the blood-brain barrier, combined with specialized Fc engineering technology, enabling customers to access more effective Alzheimer's disease treatment options. These options provide higher drug concentrations in the brain, reduce safety risks such as brain swelling, and offer the convenience of low-dose subcutaneous injections.